Bruker Corporation announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1, 2026. Mr. Phillips is a senior healthcare industry executive with over 30 years of leadership experience in the diagnostics industry. Jack Phillips served as President & CEO of Accelerate Diagnostics from 2020-2025, pioneering rapid antibiotic susceptibility testing (AST) technology for hospitals and infectious disease doctors combatting serious bacterial infections, life-threatening sepsis and antibiotic resistance.
Previously, Jack was President & CEO of Roche Diagnostics North America from 2010-2020, where he led the portfolio across clinical chemistry, immunodiagnostics, as well as molecular, tissue and point-of-care diagnostics, and digital pathology, all further strengthening Roche?s leadership position in the global in vitro diagnostics (IVD) industry. From 1999-2010, Jack was Senior VP and General Manager, North America, for Ventana Medical Systems, helping establish tissue and companion diagnostics as standards of care. His career has centered on advancing innovation to clinical translation for patient benefit and business impact through strategy, market development and operational excellence.
Jack serves on the Board of Trustees of Tucson Medical Center, and he previously was a board member of AdvaMedDx. He holds a B.S. in Marketing from Northern Kentucky University.
